drugset / Trial / NCT02197273
Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total joint arthroplasty, as compared to standard of care analgesia.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-09
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupivacaine | Other / unclassified | 266 mg | Other |
| Background | Bupivacaine | Other / unclassified | 0.25 % | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 0.5 % | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 15 ml | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 30 ml | Intrathecal |
| Background | Epinephrine | Other / unclassified | — | Other |
| Background | Fentanyl | Other / unclassified | — | Intrathecal |
| Background | Methylprednisolone | Other / unclassified | 40 mg | Other |
| Background | Morphine | Other / unclassified | 10 mg | Other |
| Background | Ropivacaine | Other / unclassified | — | Other |